• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Director Zauder Gail was granted 1,193 shares (SEC Form 4)

    7/15/25 5:00:51 PM ET
    $BSLK
    Major Chemicals
    Industrials
    Get the next $BSLK alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Zauder Gail

    (Last) (First) (Middle)
    2261 MARKET STREET, SUITE 5547

    (Street)
    SAN FRANCISCO CA 94114

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Bolt Projects Holdings, Inc. [ BLSK ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    07/11/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 07/11/2025 A 68 A $0 68(1) D
    Common Stock 07/11/2025 A 1,125 A $0 1,193(2) D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Represents an award of restricted stock units ("RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in full on the earlier of (1) the date of the Issuer's next annual meeting of stockholders and (2) July 11, 2026.
    2. Represents an award of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in three equal annual installments commencing on July 11, 2026.
    Remarks:
    /s/ Paul Joseph Slattery as Attorney-in-Fact for Gail Zauder 07/15/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $BSLK alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BSLK

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BSLK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHIEF TECHNOLOGY OFFICER Breslauer David Nate bought $975 worth of shares (300 units at $3.25), increasing direct ownership by 2% to 18,307 units (SEC Form 4)

    4 - Bolt Projects Holdings, Inc. (0001841125) (Issuer)

    6/4/25 12:17:32 PM ET
    $BSLK
    Major Chemicals
    Industrials

    INTERIM CFO Befumo Randy bought $67,260 worth of shares (29,500 units at $2.28), increasing direct ownership by 133% to 51,763 units (SEC Form 4)

    4 - Bolt Projects Holdings, Inc. (0001841125) (Issuer)

    5/30/25 10:36:28 AM ET
    $BSLK
    Major Chemicals
    Industrials

    $BSLK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Golden Arrow Sponsor, Llc sold $142,014 worth of shares (45,197 units at $3.14) (SEC Form 4)

    4 - Bolt Projects Holdings, Inc. (0001841125) (Issuer)

    8/13/25 8:19:52 PM ET
    $BSLK
    Major Chemicals
    Industrials

    Large owner Golden Arrow Sponsor, Llc sold $371,053 worth of shares (116,132 units at $3.20) (SEC Form 4)

    4 - Bolt Projects Holdings, Inc. (0001841125) (Issuer)

    7/21/25 7:11:12 PM ET
    $BSLK
    Major Chemicals
    Industrials

    Director Lucree Lorne Christopher was granted 1,193 shares (SEC Form 4)

    4 - Bolt Projects Holdings, Inc. (0001841125) (Issuer)

    7/15/25 5:03:54 PM ET
    $BSLK
    Major Chemicals
    Industrials

    $BSLK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Bolt Projects Announces $4.25 Million Private Placement

    Priced At-The-Market Under Nasdaq Rules Bolt Projects Holdings, Inc. (NASDAQ:BSLK) ("Bolt Projects" or the "Company"), a developer of biomaterials for the beauty and personal care industry, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 913,979 shares of common stock (or pre-funded warrants in lieu thereof) at a purchase price of $4.65 per share of common stock (or per pre-funded warrant in lieu thereof, less the nominal exercise price of $0.0001 per share) in a private placement priced at-the-market under Nasdaq rules. The private placement is expected to close on or about August 15, 2025, subject to the satisfaction of customa

    8/14/25 6:16:00 PM ET
    $BSLK
    Major Chemicals
    Industrials

    Bolt Projects Holdings Reports Q2 2025 Financial Results

    Bolt's second quarter 2025 Vegan Silk Technology Platform revenues grew twenty-three-fold year-over-year to $1.3 million, driven by growing commercial momentum. The Company delivered positive gross profit ahead of its internal estimate and is initiating gross profit guidance of $0.5 million for 2025 and $1.0 million for 2026. Full year revenue guidance for 2025 and 2026 remain unchanged at $4.5 million and $9.0 million, respectively. Bolt has entered into a non-binding term sheet to secure up to $20 million of financing in preferred stock and an equity line of credit from Ascent Partners to be drawn in tranches, subject to stock price, trading volume requirements and shareholder a

    8/12/25 4:41:00 PM ET
    $BSLK
    Major Chemicals
    Industrials

    Bolt Projects Holdings Reports Q1 2025 Financial Results

    In the first quarter of 2025, Vegan Silk Technology Platform revenues grew nine-fold year-over-year to $0.2 million, with gross margins at breakeven despite shipping only modest amounts in the period For full year 2025, Vegan Silk Technology Platform revenues are projected to reach at least $4.5 million, supported by multi-year supply agreements and customer expansion For full year 2026, Vegan Silk Technology Platform revenues are projected to reach at least $9.0 million, reflecting a growing customer base and successful product adoption Bolt's goal remains to achieve long-term, sustainable profitability through revenue growth, operational efficiencies, and cost of goods sold reducti

    5/12/25 5:00:00 PM ET
    $BSLK
    Major Chemicals
    Industrials

    $BSLK
    SEC Filings

    View All

    Bolt Projects Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - Bolt Projects Holdings, Inc. (0001841125) (Filer)

    8/19/25 4:08:05 PM ET
    $BSLK
    Major Chemicals
    Industrials

    Amendment: SEC Form SCHEDULE 13D/A filed by Bolt Projects Holdings Inc.

    SCHEDULE 13D/A - Bolt Projects Holdings, Inc. (0001841125) (Subject)

    8/18/25 10:30:50 AM ET
    $BSLK
    Major Chemicals
    Industrials

    SEC Form 424B3 filed by Bolt Projects Holdings Inc.

    424B3 - Bolt Projects Holdings, Inc. (0001841125) (Filer)

    8/14/25 9:29:45 AM ET
    $BSLK
    Major Chemicals
    Industrials

    $BSLK
    Leadership Updates

    Live Leadership Updates

    View All

    Bolt Projects Holdings Reports Q2 2025 Financial Results

    Bolt's second quarter 2025 Vegan Silk Technology Platform revenues grew twenty-three-fold year-over-year to $1.3 million, driven by growing commercial momentum. The Company delivered positive gross profit ahead of its internal estimate and is initiating gross profit guidance of $0.5 million for 2025 and $1.0 million for 2026. Full year revenue guidance for 2025 and 2026 remain unchanged at $4.5 million and $9.0 million, respectively. Bolt has entered into a non-binding term sheet to secure up to $20 million of financing in preferred stock and an equity line of credit from Ascent Partners to be drawn in tranches, subject to stock price, trading volume requirements and shareholder a

    8/12/25 4:41:00 PM ET
    $BSLK
    Major Chemicals
    Industrials

    $BSLK
    Financials

    Live finance-specific insights

    View All

    Bolt Projects Holdings Announces More Brands Choosing b-silk™ to Differentiate Their Product Offerings

    Over the past eighteen months, Bolt Projects Holdings (NASDAQ:BSLK) has undergone transformational change designed to accelerate penetration of its Vegan Silk Technology Platform into the beauty and personal care industry. "This effort has been led by b-silk, a novel biodegradable, film-former polypeptide designed to offer additional functional benefits for haircare, skincare and color cosmetics," said Bolt Projects Holdings Chairman and CEO Dan Widmaier. "B-silk has been in the market since 2018 and has delivered consistent and proven consumer satisfaction." During the third quarter of 2024, two new products featuring b-silk™ – the Daily Defender SPF30 and the Peak Performance SPF50 – fr

    10/22/24 9:05:00 AM ET
    $BSLK
    Major Chemicals
    Industrials

    $BSLK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Bolt Projects Holdings Inc.

    SC 13D/A - Bolt Projects Holdings, Inc. (0001841125) (Subject)

    8/30/24 4:03:55 PM ET
    $BSLK
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by Bolt Projects Holdings Inc.

    SC 13G - Bolt Projects Holdings, Inc. (0001841125) (Subject)

    8/23/24 4:37:58 PM ET
    $BSLK
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by Bolt Projects Holdings Inc.

    SC 13G - Bolt Projects Holdings, Inc. (0001841125) (Subject)

    8/23/24 4:15:56 PM ET
    $BSLK
    Major Chemicals
    Industrials